{"id":133011,"date":"2021-12-24T20:22:16","date_gmt":"2021-12-25T04:22:16","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/12\/army-to-announce-vaccine-that-protects-against-an-array-of-covid-19-variants"},"modified":"2021-12-24T20:22:16","modified_gmt":"2021-12-25T04:22:16","slug":"army-to-announce-vaccine-that-protects-against-an-array-of-covid-19-variants","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/12\/army-to-announce-vaccine-that-protects-against-an-array-of-covid-19-variants","title":{"rendered":"Army to announce vaccine that protects against an array of COVID-19 variants"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/army-to-announce-vaccine-that-protects-against-an-array-of-covid-19-variants.jpg\"><\/a><\/p>\n<p>The U.S. Army is expected to announce that it has developed a vaccine that protects against omicron and other COVID-19 variants. The Walter Reed Army Institute of Research (WRAIR) has been developing a Spike Ferritin Nanoparticle (SpFN) since early 2020, and began early-stage human trials of the vaccine in early April. Kayvon Modjarrad, director of WRAIR\u2019s infections disease branch, said that the early-stage trials ended this month, and yielded positive results that are currently under review.<\/p>\n<p>-a slight correction, but still promising.<\/p>\n<hr>\n<p>\n<em>Correction: This headline and story have been corrected to reflect that the COVID-19 vaccine the Army is developing has not been tested against omicron.<\/em><\/p>\n<p>The U.S. Army is expected to announce that it has developed a vaccine that protects against an array of COVID-19 variants, Defense One <a href=\"https:\/\/www.defenseone.com\/technology\/2021\/12\/us-army-creates-single-vaccine-effective-against-all-covid-sars-variants\/360089\/\">reported<\/a>.<\/p>\n<p>The Walter Reed Army Institute of Research (WRAIR) has been developing a spike ferritin nanoparticle (SpFN) vaccine since early 2020 and began early-stage human trials of the vaccine in <a href=\"https:\/\/thehill.com\/policy\/healthcare\/546706-human-testing-underway-for-covid-19-vaccine-developed-by-army\">early April<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Army is expected to announce that it has developed a vaccine that protects against omicron and other COVID-19 variants. The Walter Reed Army Institute of Research (WRAIR) has been developing a Spike Ferritin Nanoparticle (SpFN) since early 2020, and began early-stage human trials of the vaccine in early April. Kayvon Modjarrad, director of [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,4],"tags":[],"class_list":["post-133011","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-nanotechnology"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/133011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=133011"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/133011\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=133011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=133011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=133011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}